BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28274590)

  • 1. Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy.
    Buisan O; Orsola A; Oliveira M; Martinez R; Etxaniz O; Areal J; Ibarz L
    Clin Genitourin Cancer; 2017 Aug; 15(4):e697-e706. PubMed ID: 28274590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Buisan O; Orsola A; Areal J; Font A; Oliveira M; Martinez R; Ibarz L
    Clin Genitourin Cancer; 2017 Feb; 15(1):145-151.e2. PubMed ID: 27364982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
    Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
    Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer.
    Leibowitz-Amit R; Israel A; Gal M; Atenafu EA; Symon Z; Portnoy O; Laufer M; Dotan Z; Ramon J; Avni D; Fridman E; Berger R
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):790-796. PubMed ID: 27498850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
    World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
    Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
    BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
    Black AJ; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; McGrath JS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand S; Sridhar SS; Black PC
    Urol Oncol; 2020 Jan; 38(1):3.e17-3.e27. PubMed ID: 31676278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
    von Deimling M; Schuettfort VM; D'Andrea D; Pradere B; Grossmann NC; Kawada T; Yanagisawa T; Majdoub M; Laukhtina E; Rajwa P; Quhal F; Mostafaei H; Fajkovic H; Teoh JY; Moschini M; Karakiewicz PI; Fisch M; Rink M; Shariat SF
    Clin Genitourin Cancer; 2023 Aug; 21(4):430-441. PubMed ID: 36781346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
    Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
    Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
    Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S
    Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Wang R; Yan Y; Liu S; Yao X
    Biomed Res Int; 2019; 2019():3628384. PubMed ID: 31662975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.
    Rosenblatt R; Lorentzi G; Bahar M; Asad D; Forsman R; Johansson M; Shareef M; Alamdari F; Bergh A; Winqvist O; Sherif A
    Scand J Urol; 2020 Feb; 54(1):46-51. PubMed ID: 31960752
    [No Abstract]   [Full Text] [Related]  

  • 17. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
    BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.
    Dotson A; May A; Davaro F; Raza SJ; Siddiqui S; Hamilton Z
    Int J Clin Oncol; 2019 Jun; 24(6):706-711. PubMed ID: 30707342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.